4//SEC Filing
Sauer Paul 4
Accession 0001209191-21-057651
CIK 0001649094other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 5:04 PM ET
Size
5.3 KB
Accession
0001209191-21-057651
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Sauer Paul
SVP Process Dev, Manufacturing
Transactions
- Sale
Common Stock
2021-09-22$25.20/sh−5,307$133,724→ 36,125 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted-average price. The shares were sold at prices ranging from $25.00 to $25.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes 1,841 shares acquired under the Employee Stock Purchase Plan on May 17, 2021.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001813796
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 5:04 PM ET
- Size
- 5.3 KB